Literature DB >> 18219563

Paradigm-shifters: phosphorylated prolactin and short prolactin receptors.

KuangTzu Huang1, Eric Ueda, YenHao Chen, Ameae M Walker.   

Abstract

Since the discovery of physiologically-regulated prolactin (PRL) phosphorylation, one focus of the laboratory has been an examination of the different functions of the unmodified and phosphorylated hormone. In the mammary gland, unmodified PRL promotes growth activities, whereas phosphorylated or pseudophosphorylated PRL antagonizes this while also being a superior agonist for changes that favor differentiation. Phosphorylated PRL also increases expression of the short forms of the PRL receptor. These short forms of the receptor have functions beyond the accepted dominant negative and in mammary epithelial cells are capable of generating an intracellular signal leading to increased tight junction formation and beta-casein expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219563     DOI: 10.1007/s10911-008-9072-x

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  83 in total

1.  Identification of a nonimmunoreactive but highly bioactive form of prolactin in the mouse pituitary by gel electrophoresis.

Authors:  Y N Sinha; S R Baxter
Journal:  Biochem Biophys Res Commun       Date:  1979-01-30       Impact factor: 3.575

Review 2.  Regulation of MAP kinases by the VHR dual-specific phosphatase: implications for cell growth and differentiation.

Authors:  Fabio Cerignoli; Souad Rahmouni; Ze'ev Ronai; Tomas Mustelin
Journal:  Cell Cycle       Date:  2006-10-01       Impact factor: 4.534

Review 3.  Hormones and growth factors in milk.

Authors:  C E Grosvenor; M F Picciano; C R Baumrucker
Journal:  Endocr Rev       Date:  1993-12       Impact factor: 19.871

Review 4.  Prolactin receptor subtypes: a possible mode of tissue specific regulation of prolactin function.

Authors:  H N Jabbour; P A Kelly
Journal:  Rev Reprod       Date:  1997-01

5.  Phosphorylation of interleukin-6 at serine54: an early event in the secretory pathway in human fibroblasts.

Authors:  L T May; P B Sehgal
Journal:  Biochem Biophys Res Commun       Date:  1992-06-15       Impact factor: 3.575

6.  Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11.

Authors:  Z Z Hu; J Meng; M L Dufau
Journal:  J Biol Chem       Date:  2001-08-22       Impact factor: 5.157

7.  Identification of the major site of rat prolactin phosphorylation as serine 177.

Authors:  Y F Wang; J W Liu; M Mamidi; A M Walker
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

Review 8.  S179D prolactin: antagonistic agony!

Authors:  Ameae M Walker
Journal:  Mol Cell Endocrinol       Date:  2007-06-28       Impact factor: 4.102

9.  Phosphorylated variant of bovine prolactin.

Authors:  C L Brooks; B G Kim; P Aphale; B E Kleeman; G C Johnson
Journal:  Mol Cell Endocrinol       Date:  1990-06-18       Impact factor: 4.102

10.  Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.

Authors:  Wei Wu; Djurdjica Coss; Mary Y Lorenson; C Benson Kuo; Xiaolei Xu; Ameae M Walker
Journal:  Biochemistry       Date:  2003-06-24       Impact factor: 3.162

View more
  9 in total

1.  Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor.

Authors:  Y Sangeeta Devi; Aurora Shehu; Carlos Stocco; Julia Halperin; Jamie Le; Anita M Seibold; Michal Lahav; Nadine Binart; Geula Gibori
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

2.  Introduction: hormonal regulation of mammary development and milk protein gene expression at the whole animal and molecular levels.

Authors:  Isabel A Forsyth; Margaret C Neville
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-09       Impact factor: 2.673

3.  Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase.

Authors:  Y Sangeeta Devi; Anita M Seibold; Aurora Shehu; Evelyn Maizels; Julia Halperin; Jamie Le; Nadine Binart; Lei Bao; Geula Gibori
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

4.  Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosis.

Authors:  Yasuhiro Terasaki; Kinnosuke Yahiro; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Mario P Stylianou; Jilly F Evans; Ameae M Walker; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2010-04-22       Impact factor: 21.405

5.  Multiple cell types in the oviduct express the prolactin receptor.

Authors:  Kelly C Radecki; Matthew J Ford; Hollian R Phillipps; Mary Y Lorenson; David R Grattan; Yojiro Yamanaka; Ameae M Walker
Journal:  FASEB Bioadv       Date:  2022-04-15

6.  Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?

Authors:  Anne Q Reuwer; Patrycja Nowak-Sliwinska; Laurie A Mans; Chris M van der Loos; Jan H von der Thüsen; Marcel Th B Twickler; C Arnold Spek; Vincent Goffin; Arjan W Griffioen; Keren S Borensztajn
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

7.  Prolactin signaling through the short isoform of the mouse prolactin receptor regulates DNA binding of specific transcription factors, often with opposite effects in different reproductive issues.

Authors:  Y Sangeeta Devi; Aurora Shehu; Julia Halperin; Carlos Stocco; Jamie Le; Anita M Seibold; Geula Gibori
Journal:  Reprod Biol Endocrinol       Date:  2009-08-24       Impact factor: 5.211

8.  Prolactin and dexamethasone regulate second messenger-stimulated cl(-) secretion in mammary epithelia.

Authors:  Utchariya Anantamongkol; Mei Ao; Jayashree Sarathy Nee Venkatasubramanian; Y Sangeeta Devi; Nateetip Krishnamra; Mrinalini C Rao
Journal:  J Signal Transduct       Date:  2012-07-25

9.  Orchestration of signaling by structural disorder in class 1 cytokine receptors.

Authors:  Pernille Seiffert; Katrine Bugge; Mads Nygaard; Gitte W Haxholm; Jacob H Martinsen; Martin N Pedersen; Lise Arleth; Wouter Boomsma; Birthe B Kragelund
Journal:  Cell Commun Signal       Date:  2020-08-24       Impact factor: 5.712

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.